Efficient synthesis of (±)-seco-cyclopropaneindoline analogs of CC-1065

Heterocyclic Communications

Volumn 7, Issue 1, 2001, Pages 7-16

  Jennings, Sharon A ^a   Toth, James L ^a   Roller, Shane G ^a   Brooks, Natalie ^b   O'Hare, Caroline ^b   Kiakos, Konstantinos ^b   Hartley, John A ^b   Burke, Philip J ^c   Lee, Moses ^a  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Enazcta Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035589160     PISSN: 07930283     EISSN: None     Source Type: Journal    
DOI: 10.1515/HC.2001.7.1.7     Document Type: Article

References (46)

1. (a) Li, L.H.; Wallace, T.L.; DeKoning, T.F.; Warpehoski, M.A.; Kelly, R.C.; Prairie, M.D.; Krueger, W.C. Invest. New Drugs 1987, 5, 329.
2. (b) Li, L.H.; Kelly, R.C.; Warpehoski, M.A.; McGovern, J.P.; Gebhard, I.; DeKoning, T.F. Invest. New Drugs 1991, 9, 137.
3. (c) Warpehoski, M. In Advances in DNA Sequence Specific Agents, Vol. 1; Hurley, L.H. Ed.; JAI Press, Inc.: Greenwich, CT, 1992; p 217.
4. a) Hanka, L.J.; Dietz, A.; Gerpheide, S.A.; Kuentzel, S.L.; Martin, D.G. J. Antibiot. 1978, 31, 1211.
5. (b) McGovern, J.P.; Clarke, G.L.; Pratte, E.A.; DeKoning, T.F. J. Antibiot. 1983, 37, 63.
6. (c) Warpehoski, M.A.; Gebhard, I.; Kelly, R.C.; Krueger, W.C.; Li, L.H.; McGovern, J.P.; Prairie, M.P.; Wicnienski, N.; Wierenga, W. J. Med. Chem. 1988, 31, 590.
7. (a) Ichimura, H.; Ogawa, T.; Takahashi, K.; Kobayashi, E.; Kawamoto, I.; Yasuzawa, T.; Takahashi, I.; Nakano, H. J. Antibiot. 1990, 43, 1037.
8. (b) Yaszawa, T.; Saitoh, Y.; Ichimura, M.; Takahashi, I.; Sano, H. J. Antibiot. 1991, 44, 445.
9. (c) Yasuzawa, T.; Muroi, K.; Ichimura, M.; Takahashi, I.; Ogawa, T.; Takahashi, K.; Sano, H.; Saitoh, Y. Chem. Pharm. Bull. 1995, 43, 378.
10. (d) Ichimura, M.; Ogawa, T.; Takahashi, K.; Mihara, A.; Takahashi, I.; Nakano, H. Oncol. Res. 1993, 5, 165.
11. (e) Gomi, K.; Kobayashi, E.; Miyoshi, K.; Ashizawa, T.; Okamoto, A.; Ogawa, T.; Katsumata, S.; Mihara, A.; Okabe, M.; Hirata, T. Jpn. J. Cancer Res. 1992, 83, 113.
12. (a) Boger, D.L.; Johnson, D.S. Angew. Chem. Int. Ed. Engl. 1996, 35, 1438.
13. (b) Boger, D.L.; Johnson, D.S. Proc. Natl. Acad. Sci. USA 1995, 92, 3642.
14. (c) Boger, D.L. Acc. Chem. Res. 1995, 28, 20.
15. (d) Boger, D.L. Chemtracts: Org. Chem. 1991, 4, 329.
16. (a) Boger, D.L.; Bollinger, B.; Hertzog, D.L.; Douglas, S.J.; Cai, H.; Mesini, P.; Garbaccio, R.M.; Jin, Q.; Kitos, P.A. J. Am. Chem. Soc. 1997, 119, 4987.
17. (b) Boger, D.L.; Garbaccio, R.M. Bioorg. Med. Chem. 1997, 5, 263.
18. (c) Eis, P.S.; Smith, J.A.; Rydzewski, J.M.; Case, D.A.; Boger, D.L.; Chazin, W.J. J. Mol Biol. 1997, 272, 237.
19. (a) Hurley, L.H.; Reynolds, V.S.; Swenson, D.H.; Petzold, G.L.; Scahill, T.A. Science 1984, 226, 843.
20. (b) Warpehoski, M.A.; Hurley, L.H. Chem. Res. Toxicol. 1988, 1, 315.
21. (c) Lin, C.H.; Sun, D.; Hurley, L.H. Chem. Res. Toxicol. 1991, 4, 21.
22. (d) Warpehoski, M.A.; Harper, D.E. J. Am. Chem. Soc. 1994, 116, 7573.
23. (e) Scahill, T.A.; Jensen, R.M.; Swenson, D.H.; Hatzenbuhler, N.T.; Petzold, G.; Wierenga, W.; Brahme, N.D. Biochemistry 1990, 29, 2852.
24. (f) Hurley, L.H.; Draves, P.H. in Molecular Aspects of Anticancer Drug-DNA Interactions, Vol. 1; Neidle, S.; Waring, M. Eds.; CRC Press: Boca Raton, F1, 1993; p 89.
25. (g) Lin, C.H.; Hill, C.G.; Hurley, L.H. Chem. Res. Toxicol. 1992, 5, 167.
26. (h) Powers, R.; Gorenstein, D.G. Biochemistry, 1990, 29, 9994.
27. Boger, D.L.; Johnson, D.S.; Yun, W. J. Am. Chem. Soc. 1994, 116, 1635.
28. Reynolds, V.L.; Molineux, I.J.; Kaplan, D.J.; Swenson, D.H.; Hurley, L.H. Biochemistry 1985, 24, 6228.
29. (a) Boger, D.L.; Munk, S.A.; Zarrinmayeh, H.; Ishizaki, T.; Haught, J.; Bina, M. Tetrahedron 1991, 47, 2661.
30. (b) Boger, D.L.; Zarrinhmayeh, H.; Munk, S.A.; Kitos, P.A.; Suntomwat, O. Proc. Natl. Acad. Sci. USA 1991, 88, 1431.
31. (a) Boger, D.L.; Wysocki, Jr., R.J. J. Org. Chem. 1989, 54, 1238.
32. (b) Boger, D.L.; Wysocki, Jr., R.J.; Ishizaki, T. J. Am. Chem. Soc. 1990, 112, 5230.
33. (c) Boger, D.L.; Ishizaki, I.; Zarrinhmayeh, H.; Munk, S.A.; Kitos, P.A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961.
34. (d) Boger, D.L.; Ishizaki, I.; Zarrinhmayeh, H.; Kitos, P.A.; Suntornwat, O. J. Org. Chem. 1990, 55, 4499.
35. (a) Drost, K.J.; Jones, R.J.; Cava, M.P. J. Org. Chem. 1989, 54, 5985.
36. (b) Tidwell, J.H.; Buchwald, S.L.J. Org. Chem. 1992, 57, 6380.
37. (c) Wang, Y.; Gupta, R.; Huang, L.; Lown, J.W. J. Med. Chem. 1993, 36, 4172.
38. (d) Chenevert, R.; Courchesne, G. Chem. Lett. 1997, 11.
39. (e) Fan, J-Y.; Tercel, M.; Denny, W.A. Anti-Cancer Drug Design 1997, 12, 277.
40. Burris, H.A.; Dleras, V.C.; Tunca, M.; Earhart, R.H.; Eckardt, J.R.; Rodriguez, G.I.; Shaffer, D.S.; Fields, S.M.; Campbell, E.; Schaaf, L.; Kasunic, D.; Von Hoff, D.D. Anti-Cancer Drugs 1997, 8, 588.
41. Harschman, K.; Dervan, P.B. Nucl. Acids Res. 1985, 13, 4825.
42. Dervan, P.B. Science 1986, 232, 464.
43. The synthetic procedures and characterization data for 2-(4-(N,N-diethyl)aminophenyl)benzimidazole-6-carboxylic acid and 4-(4-butanamido-1-methylpyrrole-2-carboxamido)-1-methylpyrrole-2-carboxylic acid can be obtained from the authors.
44. Carmichael, J.; DeGraff, W.G.; Gadzar, A.F.; Minna, J.D.; Mitchell, J.B. Cancer Res. 1987, 47, 936.
45. Fukuda, Y.; Itoh, Y.; Nakatani, K.; Terashima, S. Tetrahedron 1994, 50, 2793.
46. Warpehoski, M.A. Tetrahedron Lett. 1986, 27, 4103, and references therein.